MACKENZIE MCCROREY: Open Payments
NPI 1023271632 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 13 payments from 9 companies in 2025. Trend: 2023 $153 · 2024 $249 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Getinge USA Sales, LLC | 1 | $61 |
| Merck Sharp & Dohme LLC | 2 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $56 |
| ABIOMED | 1 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $19 |
| Octapharma USA, Inc. | 1 | $18 |
Products named: VASOVIEW HEMOPRO 2, KEYTRUDA, LifeVest, JOURNAVX, Kerendia, PREVELEAK, FIBRYGA.
Industry payments across OR — which companies pay providers there.
